EURAND IN-LICENSES NOVEL ANALGESICS

摘要

Eurand,a specialty pharmaceutical company,has signed research agreements with the University of Milan(Italy)and the University of Sassari(Italy)to evaluate a new class of analgesic compounds.This new class of compounds is expected to be comparable to opioids in terms of efficacy,but not to possess the major drawbacks of tolerance and dependence which limits the use of opioids,the gold standard in pain relief.